Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

G. Rosati; G. Aprile; Mario Scartozzi; F. Pasini; M. Cantore; D. Ferrari; S. Barni; R. Labianca; TOSCA (Three or Six Colon Adjuvant) Investigators; Guglielmo Nasti; Rosario Vincenzo Iaffaioli

doi:10.1093/annonc/mdw404

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

G. Rosati, G. Aprile, Mario Scartozzi, F. Pasini, M. Cantore, D. Ferrari, S. Barni, R. Labianca, TOSCA (Three or Six Colon Adjuvant) Investigators, Guglielmo Nasti, Rosario Vincenzo Iaffaioli

Istituto Nazionale Tumori Fondazione G. Pascale

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Pages (from-to)	2074-2081
Number of pages	8
Journal	Annals of Oncology
Volume	27
Issue number	11
DOIs	https://doi.org/10.1093/annonc/mdw404
Publication status	Published - Nov 1 2016

Keywords

Journal Article

Access to Document

10.1093/annonc/mdw404

Cite this

Rosati, G., Aprile, G., Scartozzi, M., Pasini, F., Cantore, M., Ferrari, D., Barni, S., Labianca, R., Investigators, TOSCA. T. O. S. C. A., Nasti, G., & Iaffaioli, R. V. (2016). Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial. Annals of Oncology, 27(11), 2074-2081. https://doi.org/10.1093/annonc/mdw404

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial. / Rosati, G.; Aprile, G.; Scartozzi, Mario; Pasini, F.; Cantore, M.; Ferrari, D.; Barni, S.; Labianca, R.; Investigators, TOSCA (Three or Six Colon Adjuvant); Nasti, Guglielmo; Iaffaioli, Rosario Vincenzo.

In: Annals of Oncology, Vol. 27, No. 11, 01.11.2016, p. 2074-2081.

Research output: Contribution to journal › Article › peer-review

Rosati, G, Aprile, G, Scartozzi, M, Pasini, F, Cantore, M, Ferrari, D, Barni, S, Labianca, R, Investigators, TOSCATOSCA, Nasti, G & Iaffaioli, RV 2016, 'Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial', Annals of Oncology, vol. 27, no. 11, pp. 2074-2081. https://doi.org/10.1093/annonc/mdw404

Rosati, G. ; Aprile, G. ; Scartozzi, Mario ; Pasini, F. ; Cantore, M. ; Ferrari, D. ; Barni, S. ; Labianca, R. ; Investigators, TOSCA (Three or Six Colon Adjuvant) ; Nasti, Guglielmo ; Iaffaioli, Rosario Vincenzo. / Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial. In: Annals of Oncology. 2016 ; Vol. 27, No. 11. pp. 2074-2081.

@article{2b3bcaa3f9a34a78a024c9ebc5a27dfc,

title = "Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial",

keywords = "Journal Article",

author = "G. Rosati and G. Aprile and Mario Scartozzi and F. Pasini and M. Cantore and D. Ferrari and S. Barni and R. Labianca and Investigators, {TOSCA (Three or Six Colon Adjuvant)} and Guglielmo Nasti and Iaffaioli, {Rosario Vincenzo}",

note = "{\textcopyright} The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.",

year = "2016",

month = nov,

day = "1",

doi = "10.1093/annonc/mdw404",

language = "Non definita",

volume = "27",

pages = "2074--2081",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

number = "11",

}

TY - JOUR

T1 - Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

AU - Rosati, G.

AU - Aprile, G.

AU - Scartozzi, Mario

AU - Pasini, F.

AU - Cantore, M.

AU - Ferrari, D.

AU - Barni, S.

AU - Labianca, R.

AU - Investigators, TOSCA (Three or Six Colon Adjuvant)

AU - Nasti, Guglielmo

AU - Iaffaioli, Rosario Vincenzo

PY - 2016/11/1

Y1 - 2016/11/1

KW - Journal Article

U2 - 10.1093/annonc/mdw404

DO - 10.1093/annonc/mdw404

M3 - Articolo

VL - 27

SP - 2074

EP - 2081

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 11

ER -